FDA ApprovedUnited States
New Treatment for Immune-Related Anemia in Teens and Adults
Imaavy (nipocalimab-aahu) — neonatal Fc receptor blocker for warm autoimmune hemolytic anemia in adults and adolescents 12 years and older after corticosteroid exposure
FDA approval on 25 August 2026 for Imaavy (nipocalimab-aahu) injection — a neonatal Fc receptor (FcRn) blocker — for warm autoimmune hemolytic anemia (wAIHA)…
This is for people 12 years and older with warm autoimmune hemolytic anemia who are currently on or have previously received corticosteroids and who may be…